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Background: Compared to the posterior approach, the anterior approach to total hip arthroplasty (THA)
offers the potential for an accelerated recovery secondary to less dissection and therefore less pain in the
immediate postoperative period. This offers potential ﬁnancial beneﬁt through a reduction in length of
stay. This study retrospectively reviewed 98 anterior approach and 69 posterior approach THA cases (N ¼
167) to compare perioperative outcomes and cost-effectiveness.
Methods: Patients who underwent anterior approach THA were discharged sooner than those who
underwent posterior approach THA.
Results: The anterior approach was also less expensive per patient than the posterior approach. Overall,
differences in perioperative outcomes between these approaches to THA are less robust than previously
reported. There is a signiﬁcant difference in operative cost between these surgical approaches.
Conclusions: Although there are many sources for this difference in cost, the predominant contributor is
surgeon implant preference.
Copyright © 2016 The Authors. Published by Elsevier Inc. on behalf of American Association of Hip and
Knee Surgeons. This is an open access article under the CC BY-NC-ND license (http://creativecommons.
org/licenses/by-nc-nd/4.0/).Introduction in previous work to cause less soft tissue damage, decrease post-Traditionally, one of the most common surgical approaches to
total hip arthroplasty (THA) has been the posterior approach (PA),
in which the hip joint is accessed by splitting the gluteus maximus
muscle [1,2]. However, in recent years, there has been increasing
focus on minimally invasive surgical approaches to THA because of
the potential to improve perioperative outcomes and hasten pa-
tient recovery [2-4]. The anterior, or Smith-Petersen, surgical
approach has been shown to improve functional recovery in the
early postoperative period [5-10]. Although the AA and PA have
comparable long-term success rates, discrepancy is reported in the
early postoperative period [2,4,6,11]. The anterior approach (AA)
uses the intermuscular and internervous intervals between the
sartorius and the tensor fascia lata muscles. This has been reportedclosed potential or pertinent
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compared to cases using the PA [12-18]. In addition, patients who
underwent AA THAweremore likely to be discharged to home vs to
rehabilitation when compared to patients receiving the PA [12-15].
These outcomes offer signiﬁcant beneﬁts for patients in the im-
mediate postoperative period, as well as the potential to decrease
hospital costs. Furthermore, the demand for THA is expected to rise
over the next decade because of an aging and increasingly seden-
tary United States population [19,20]. Therefore, improvements in
THA that can decrease length of recovery may signiﬁcantly impact
health care costs through a reduction in needed medical services.
Thepurposeofourstudy is toreviewtheperioperativeandﬁnancial
results of THA performed through the AA vs PA to compare their
perioperative outcomes and cost-effectiveness. Given the muscle-
sparing nature of the AA and based on previous research, we hypoth-
esized that patients who underwent AA THAwould have a decreased
length of hospital stay resulting in considerable cost reduction.
Material and methods
We obtained institutional review board approval at our institu-
tion to retrospectively evaluate 98 AA and 69 PATHA cases (N¼ 167)
which took place between January and June of 2013. All AA THAsan Association of Hip and Knee Surgeons. This is an open access article under the CC
al hip arthroplasty: a comparison of anterior versus posterior surgical
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Table 1
Characteristics of study population.
Characteristics Anterior
(n ¼ 98)
Posterior
(n ¼ 69)
P value
Age 61.13 62.9 .12
Gender
Male 45 (46%) 34 (49%) .79
Female 53 (54%) 35 (51%)
BMI 30.38 30.72 .39
ASA 2.44 2.39 .28
Surgical indications
Osteoarthritis 96 (98%) 62 (90%)
Avascular necrosis 1 (1%) 4 (6%)
Developmental dysplasia of hip 1 (1%) 1 (1%)
Fracture 0 2 (3%)
ASA, American Society of Anesthesiologists; BMI, body mass index.
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arthroplasty surgeon. A different surgeon with a similar back-
ground performed all PA THAs. Patient demographics included age,
gender, American Society of Anesthesiologists score, body mass in-
dex, and surgical indication. Operative records were analyzed for
perioperative outcomes including surgical time, blood loss, pain
(visual analog scale pain score, 1- to 10-point scale), complications,
discharge disposition (home or rehabilitation facility), and LOS.
Complications were deﬁned as undesired or unexpected results of
the operation including, but not limited to, dislocation, infection,
heterotopic ossiﬁcation, and limb length discrepancy. All AA cases
used the same implants: a Pinnacle uncemented acetabular
component, a highly cross-linked polyethylene liner, a Trilock BPS
uncemented femoral stem, and a Biolox Delta ceramic femoral head
(all Depuy,Warsaw, IN). All PAcasesused aZimmerTrabecularmetal
cup, a highly cross-linked polyethylene liner, a metal stem, and a
cobalt chromium head (all Zimmer, Warsaw, IN). All patients were
treated at a single location in the same academic medical center.
The AA was performed with the patient in the supine position
on a HANA (Mizuho OSI, Union City, CA) operative table. The inci-
sion started 2 cm distal to and 2 cm posterior to the anterior su-
perior iliac spine and continued distally for 8-10 cm in alignment
with the lateral edge of the patella. This approach, between the
tensor fascia lata and the sartorius muscles, has been described
previously in greater detail [10,11,14,21]. The PA was performed
with the patient in the lateral decubitus position on a standard
operating table and pegboard. A posterior oblique incision was
made centered over the posterior tip of the greater trochanter. The
gluteus maximus muscle ﬁbers were split, and the piriformis and
conjoined tendon were reﬂected. The PA is also well described in
previous orthopaedic texts [14,21,22].
We conducted ﬁnancial analyses based on data compiled from
the institution’s ﬁnance department. Cost was separated into direct
and indirect categories. Direct costs included all expenses imme-
diately associated with the surgical procedure, whereas indirect
costs were facility, overhead, support, and administrative in nature.
Relevant direct cost items included anesthesia, blood bank, imag-
ing, laboratories, operating room (OR) supplies/implants, OR time,
postanesthesia care unit and supplies, pharmacy, physical therapy/
occupational therapy, radiation oncology, respiratory, and routine
room and board (RMBD). Costs associated with the surgical
approach but not grouped into another category were deﬁned as
others. These costs included vascular laboratory and noninvasive
cardiology expenses, critical care support services, gastrointestinal
services, and others. We calculated the total cost of the surgical
procedure by approach and the median cost per approach. Because
of differences in implant usage and physician preference regarding
postoperative pain medication, the total procedural costs were
corrected to exclude pharmaceutical and implant costs.
We performed a statistical analysis of the data by calculating the
mean, median, standard deviation, and range for continuous vari-
ables and frequencies and percentages of categorical variables
where appropriate. Median cost was determined where the
assumption of normal distribution could not be made. Differences
in the averages for continuous variables between anterior and PA
patients were tested using Student’s t tests when the assumption of
normality was satisﬁed. Mann-Whitney tests were used when such
an assumption could not bemade. Pearson’s chi-square and Fisher’s
exact tests were used to examine differences in categorical vari-
ables. A P value of<.05was considered to be a signiﬁcant difference.
Results
Financial and perioperative outcomes of 167 THAs performed
within a 6-month period were reviewed. Ninety-eight THAs werePlease cite this article in press as: N.M. Joseph, et al., Financial impact of tot
approaches, Arthroplasty Today (2016), http://dx.doi.org/10.1016/j.artd.2performed via the AA and 69 via the PA. Patient demographic data
illustrated that patients in the AA and PA groups were similar in
terms of age, gender, body mass index, and American Society of
Anesthesiologists score (P > .05), as differences were found not to
be statistically signiﬁcant (Table 1). In both groups, the predomi-
nant indication for surgery was degenerative osteoarthritis.
Data related to the procedure and hospitalization showed
several differences between the 2 groups. Mean surgical time was
almost 7 minutes longer in the AA group than in the PA group (94.8
vs 88.3 minutes, P¼ .005, Table 2). Mean length of hospital stay was
shorter in the AA group than in the PA (LOS: 2.12 vs 2.4 days, P ¼
.0132, Table 2). The majority of patients in both groups had an LOS
of 2 days (Table 3). However, a larger proportion of the AA patients
were discharged to home vs to a rehabilitation facility (87.8% vs
71%, P ¼ .012, Table 2).
Perioperative outcomes indicate that the AA patients experi-
enced greater blood loss (452.6 vs 267.5 mL, P < .0001) and a
greater reduction in pain (visual analog scale score: 3.5 vs 2.14, P ¼
.0003). There were fewer complications (2% vs 4%, P ¼ .64) noted in
the AA group, but the difference in incidence of complications was
not found to be statistically signiﬁcant (P ¼ .64, Table 4).
Financial results illustrated that the direct cost of AA THA was
$1002 more than the PA per patient ($13,342 vs $12,340; Table 5).
However, when the direct cost was adjusted to account for prices
of implants used and medications provided, the PA THA costs were
$580more than the AA per patient (P¼ .001, Table 5). Based on the
categorical direct cost data, the greatest difference in cost between
the 2 approaches was in OR supplies/implants ($1493, Table 6).
Differences in OR time, imaging, radiation oncology, and other
costs were also signiﬁcant contributors to the resultant cost dif-
ference (Table 6). In general, the costs associated with OR supplies/
implants (AA: $8801, PA: $7308), OR time (AA: $1569, PA: $1397),
and routine RMBD (both $916) comprised the greatest portion of
the total cost of the procedure for each patient (Table 6). It is
important to note that 9 PA patients, compared to just 1 AA pa-
tient, used radiation oncology services for prophylaxis and/or
treatment for heterotopic ossiﬁcation, costing between $575 and
$1079 (Table 6).
Discussion
In this study, we compare early perioperative and ﬁnancial
outcomes of AA vs PA THAs. The results indicate that the patients
who underwent the AA had a shorter LOS in the hospital than the
patients who underwent the PA. However, the resultant impact on
cost was minimal. When comparing direct costs of the surgical
procedure, the AAwasmore expensive than the PA primarily due to
the greater cost of the implant used in AA patients, a cost largelyal hip arthroplasty: a comparison of anterior versus posterior surgical
016.01.002
Table 2
Characteristics of surgical procedure/hospitalization.
Characteristics Anterior (n ¼ 98) Posterior (n ¼ 69) P value
Anesthesia
General 47 (48%) 60 (87%)
Regional 51 (52%) 9 (13%)
Surgical time, min 94.8 ± 15 88.3 ± 17.6 .005
Length of stay, d 2.12 2.40 .0132
Discharge to
Home 86 (87.8%) 49 (71%)
Rehab 12 (12.2%) 20 (29%) .012
Table 4
Perioperative outcomes by surgical approach.
Outcome Anterior Posterior P value
Blood loss, mL 452.6 267.5 <.0001
Transfusion, U PRBCs 0.52 0.47 .35
Transfusion needed 32 (33%) 19 (28%)
Pain
Post-op VAS score 5.74 5.3 .12
Discharge VAS score 2.24 3.16 .0065
Reduction in pain score 3.5 2.14 .0003
Complications
Dislocation 1 0
Infection 1 1
Heterotopic ossiﬁcation 0 1
Post-op limb length discrepancy 0 1
Total incidence 2 (2%) 3 (4%) .64
Post-op, postoperative; PRBCs, packed red blood cells; VAS, visual analog scale.
Table 5
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PA only when adjusting for such physician preference for the
implant used, as well as for pharmacy needs. These results indicate
that factors unrelated to immediate perioperative outcomes can
signiﬁcantly impact the procedure cost. In the absence of robust
differences in perioperative outcomes, these costs are most prom-
inent. To our knowledge, this is the ﬁrst study to report cost out-
comes associated with different approaches to THA.
Themuscle-sparing nature of the AATHA theoretically offers the
potential for a greater patient beneﬁt in the immediate post-
operative period. Several recent studies have reported decreased
pain, increased mobility, and less use of assistive devices and pain
medication with the AA in the early postoperative period [11-15].
Earlier discharge to home has also been reported [6-15]. Zawadsky
et al. [12] suggested that these improvements in the early post-
operative period could lead to decreased hospital costs through
decreased utilization of services. Our results support this position,
as reductions in OR time and routine RMDB can meaningfully
reduce procedure costs.
Although many of the perioperative outcomes we report are
consistent with recent literature comparing the AA to alternative
transgluteal approaches, the differences we found were not as
robust. Although statistically signiﬁcant, AA THA patients were only
discharged 0.28 days sooner than PA patients. Based on the LOS
distribution, it is evident that the overwhelming majority of pa-
tients in both groupswere being discharged on postoperative day 2.
This contrasts with several studies that reported a decrease in LOS
of at least 1 day with the AA compared to an alternative approach
[11-14]. The small difference in LOS we obtained might be
explained by the discharge disposition, as PA patients were more
likely to be discharged to rehabilitation vs to home. However, the
earlier discharge rates for patients undergoing each approach
illustrate that beneﬁts attributed to minimally invasive approaches
might also be obtained in traditional transgluteal approaches. With
technological advancements and reﬁnements of prostheses,
instrumentation, and techniques, this is becoming increasingly
plausible.
Despite these minor differences in perioperative outcomes, the
PAwas $580more expensive per patient. In the context of this two-
surgeon, 167-patient study, this amounts to a $96,860 difference in
cost for our institution over the 6-month period alone. However,
categorical breakdown of direct costs shows that the increased
expense in the PA when excluding OR supplies/implants and
pharmacy was due to radiation oncology and other costs. Radiation
oncology services were used for prophylaxis and/or treatment ofTable 3
Distribution of length of hospital stay by approach.
Days 2 3 4 Total P value
Anterior 86 11 1 98
Posterior 49 15 5 69 .0132
Please cite this article in press as: N.M. Joseph, et al., Financial impact of tot
approaches, Arthroplasty Today (2016), http://dx.doi.org/10.1016/j.artd.20heterotopic ossiﬁcation. In our study, 9 PA patients required this
treatment compared to 1 patient in the AA cohort. Heterotopic
ossiﬁcation is a frequent complication after THA, irrespective of
approach, resulting from the displacement of osteoprogenitor cells
during reaming and broaching processes [23]. However, the deci-
sion to use radiation prophylaxis might also vary based on surgeon
preference similar to the choice of implant used. Nevertheless, ra-
diation oncology services are a signiﬁcant expense and were used
more frequently with patients who underwent the PA. Therefore,
further study is warranted to determine the clinical rationale for
these services to truly illustrate the effects of this treatment on cost.
Routine RMBD is also a signiﬁcant expense associated with THA.
In our cohort, there was no difference in cost of routine RMBD
between the 2 approaches, which is not surprising based on a
similar mean LOS. The AA allowed patients to be discharged about a
third of a day sooner compared to the PA. This difference in LOS is
less demonstrable than what has been previously cited in the
literature [11,12,14,15]. Nevertheless, its directionality is important
to the ﬁnances of a medical institution, as the aggregate difference
across numerous patients produces signiﬁcant savings for hospi-
tals. Furthermore, we report that a greater proportion of patients
who underwent PA THAwere discharged to a rehabilitation facility
vs to home compared to AA patients. We did not report the addi-
tional cost of this rehabilitation, yet it represents a signiﬁcant
additional cost to the health care system at large. Therefore, it is
likely that the overall difference in cost between the 2 approaches
we report is an underestimation. Further follow-up analysis of the
costs associated with rehabilitation from both surgical approaches
is warranted.
OR time is another signiﬁcant driver of cost associatedwith THA.
AA patients spent only 7 minutes more in the OR than those pa-
tients undergoing the PA. Although this may be a small difference in
OR time, it accounted for $173 in excess cost per patient. Multiplied
over 69 patients, it becomes clearer how cost reductions can occur
through greater OR time efﬁciency.
Although recent literature supports minimally invasive ap-
proaches such as the AA to THA, uniform consensus has not been
established. Several studies have suggested no signiﬁcantMedian cost outcomes per patient by surgical approach.
Approach Direct
cost
Indirect
cost
Total
cost
Total minus
OR supplies/
implants and
pharmacy
Direct minus
OR supplies/
implants and
pharmacy
P value
Anterior $13,342 $6362 $19,704 $10,624 $4262
Posterior $12,340 $5564 $17,904 $10,406 $4842
Difference $1002 $798 $1800 $219 $580 .001
al hip arthroplasty: a comparison of anterior versus posterior surgical
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Table 6
Median direct cost outcomes per patient by cost category.
Cost category Anterior (range) Posterior (range) Difference
(AeP)
Anesthesia $341 ($299-$716) $341 ($291-$605) $0
Blood bank $59 ($38-$1096) $59 ($38-$1918) $0
Imaging $200 ($63-$605) $63 ($63-$1945) $137
Laboratories $84 ($84-$556) $91 ($84-$552) $7
OR supplies/
implants
$8801 ($7202-$17,983) $7308 ($7202-$12,001) $1493
OR time $1569 ($898-$1726) $1397 ($898-$2023) $173
Other $3 ($3-$950) $328 ($273-$383) $325
PACU $243 ($71-$2416) $310 ($71-$793) $67
PACU supplies $1 ($1-$52) $1 ($1-$104) $0
Pharmacy $279 ($119-$5097) $191 ($69-$1410) $88
PT/OT $235 ($157-$518) $272 ($131-$681) $37
Radiation
oncology
$575a $1029 ($575-$1079)a $454
Respiratory $36 ($18-$386) $36 ($17-$507) $0
Routine RMDB $916 ($916-$6276) $916 ($916-$3483) $0
AP, anterior minus posterior; PACU, postanesthesia care unit; PT/OT, physical
therapy/occupational therapy.
a Only 1 anterior approach patient used radiation oncology compared to 9 pos-
terior approach patients.
N.M. Joseph et al. / Arthroplasty Today xxx (2016) 1e54difference in early outcomes, whereas others cited increased
complication rates, increased blood loss and surgical time, and a
steep learning curve causing poorer outcomes during the training
period [7,8,12,24,25]. It should be noted that inﬂuence of both de-
mographic disparities and learning curve issues were minimized in
our study, as patient demographics were found to be similar be-
tween the 2 groups and both contributing surgeons had signiﬁcant
prior experience in THA using their respective approaches. Studies
have also reported conﬂicting results regarding the efﬁcacy of the
AA in minimizing soft tissue damage [16,18]. In addition,
Christensen et al. [26] have reported a higher incidence of acute
wound complications that required reoperation in patients who
underwent AA THA compared to the PA. In the absence of uniform
agreement in the literature regarding the clinical efﬁcacy associ-
ated with either approach, any differences in cost-effectiveness
could play a signiﬁcant role in guiding treatment.
Cost is a relevant consideration for institutions and surgeons in
current health care practice. Financial consideration in THA is of
particular interest given current and projected increases in demand
for this procedure [19,20]. Moreover, recent interest in alternative
and minimally invasive approaches has the potential to stimulate
demand. Woolson et al. [7] described a substantial increase in
procedure volume after the marketing of the AA as minimally
invasive. Martin et al. [14] discussed the potential for cost
discrepancy between approaches toTHA based on differences in OR
time, length of hospital stay, and routine inpatient accommoda-
tions. Our results demonstrate no substantial differences in cost
related to these perioperative factors.
Institutions must also consider signiﬁcant upfront costs in
specialty equipment, training, and the learning curve that are
associated with an alternative approach. These upfront costs might
be offset by potential future reductions in medical services needed.
Treatment options that offer superior or equivalent clinical out-
comeswhile using fewermedical resources at a subsequently lower
cost would be strongly considered by both orthopaedic surgeons
and administrators alike. Our ﬁndings support greater savings with
the AA only when controlling for implant and pharmacy costs. We
acknowledge that greater cost differences might be found at in-
stitutions where there is a larger discrepancy in perioperative
outcomes between the AA and the PA.
One important caveat is that signiﬁcant geographic diversity
exists across the United States with respect to medical costs.Please cite this article in press as: N.M. Joseph, et al., Financial impact of tot
approaches, Arthroplasty Today (2016), http://dx.doi.org/10.1016/j.artd.2Therefore, the magnitude of cost difference reported here might
not be comparable to that at another institution. Nevertheless,
similar trends might be extrapolated from the results we have
provided. We showed that other costs not associated with routine
inpatient care, OR time, or implants did signiﬁcantly affect costs.
Thus, further study is warranted to examine whether costs accrued
as a byproduct of the surgical procedure, from the early post-
operative recovery experience (ie, pain management), or from
variability in physician preference could account for cost
differences.
Our study has several limitations. Notably, it was a retrospective
2-surgeon study. Therefore, we could not ensure identical periop-
erative medication protocols and implants used. As a result, we also
report cost corrected for OR supplies/implants and pharmacy.
Although pharmacy costs were not expensive, OR supplies/im-
plants were by far the greatest cost driver associated with the
procedure and, when not excluded, changed the direction and
magnitude of the cost difference. There is substantial variability in
cost for different types of implants used for primary THA, with a
difference of more than $1500 between most and least expensive
constructs [27]. Therefore, cost-efﬁciency with respect to implant
selection can signiﬁcantly reduce operative costs. Radiation
oncology services, in the form of radiation prophylaxis for hetero-
topic ossiﬁcation, represent another cost that might demonstrate
interprovider variation. Subsequent study with standardization in
these areas might yield meaningful results. Furthermore, Pour et al.
[28] showed that numerous factors other than the surgical
approach, such as patient preconditioning, preemptive analgesia,
and rehabilitation protocol, signiﬁcantly impacted the outcome of
THA. Therefore, controlling for these parameters might also be
pertinent in subsequent study.
In addition, our study examined perioperative outcomes only up
to discharge from the hospital. Therefore, the potential exists for
more long-term outcomes, and subsequent costs, to change
whether patients experienced any other complications (ie, dislo-
cation, loosening, and so forth). Any rehospitalization that may
have occurred secondary to the THA and/or any surgical revision
required would invariably signiﬁcantly increase health care costs.
This warrants further follow-up.
In summary, we reported minor differences in perioperative
outcomes between the AA and PA THAs within the hospital
admission, including increased OR time and greater blood loss with
the AA despite its decreased LOS. These differences in clinical
outcomes do not explain the difference in cost between the ap-
proaches, whereas differences in OR supplies/implant and radiation
oncology costs do. The PA was only more expensive than the AA
after excluding OR supplies/implant and pharmacy costs, and if
radiation oncology costs were also excluded, the cost difference
would be negligible. This illustrates the existence of inherent dif-
ferences in medical service utilization between the 2 approaches
that merits further study. Furthermore, because more patients who
underwent PA THA were discharged to rehabilitation, we are likely
underestimating the overall cost of immediate recovery, as addi-
tional rehabilitation costs are deferred to the rehabilitation facility.
Therefore, even if differences in cost between approaches were
equivocal in the acute perioperative period, the AA is favorable as it
likely generates a lesser ﬁnancial burden to the health care system.
Overall, surgeon preference and experience tend to dictate the
surgical approach used. However, with intense cost pressures faced
by hospitals and surgeons in the current health care market, it may
be prudent to consider cost-efﬁciency with any procedure. At in-
stitutions considering the use of alternative approaches to THA,
clinical indications should be assessed in relation to the feasibility
of investment in training, equipment, and services necessary for theal hip arthroplasty: a comparison of anterior versus posterior surgical
016.01.002
N.M. Joseph et al. / Arthroplasty Today xxx (2016) 1e5 5approach. Further research is necessary to elaborate on prospective
cost differences associated with recovery in the long term.Conclusions
Financial consideration in THA is of interest given current and
projected increases in demand for this procedure. Major cost
drivers for this procedure include OR supplies/implants, OR time,
and RMBD. When comparing anterior vs posterior surgical
approach THAs, there were minimal differences in acute periop-
erative clinical outcomes, including LOS, which marginally
impacted the difference in cost between the approaches. A cost
differential was present largely as a result of physician preference
for supplies/implant and ancillary interventions, such as hetero-
topic ossiﬁcation prophylaxis. However, patients who underwent
PA THA were more likely to be discharged to rehabilitation vs to
home. Thus, when consideration is given to the total cost of the
procedure and the recovery period, we are likely underestimating
the overall cost difference between these approaches. Further study
is warranted to assess these prospective total cost differences.References
1. Vail TP, Callaghan JJ. Minimal incision total hip arthroplasty. J Am Acad Orthop
Surg 2007;15:707.
2. Post ZD, Orozco F, Diaz-Ledezma C, Hozack WJ, Ong A. Direct anterior approach
for total hip arthroplasty: indications, technique and results. J Am Acad Orthop
Surg 2014;22(9):595.
3. Pospischill M, Kranzl A, Attwenger B, Knahr K. Minimally invasive compared
with traditional transgluteal approach for total hip arthroplasty: a comparative
gait analysis. J Bone Joint Surg Am 2010;92:328.
4. Hartzband MA. Posterolateral minimal incision for total hip replacement:
technique and early results. Orthop Clin North Am 2004;35:119.
5. Light TR, Keggi KJ. Anterior approach to hip arthroplasty. Clin Orthop Relat Res
1980;152:255.
6. Kennon RE, Keggi JM, Wetmore RS, et al. Total hip arthroplasty through a
minimally invasive anterior surgical approach. J Bone Joint Surg Am 2003;85:
39.
7. Woolson ST, Pouliot MA, Huddleston JI. Primary total hip arthroplasty using an
anterior approach and a fracture table: short-term results from a community
hospital. J Arthroplasty 2009;24:999.
8. Matta JM, Shahrdar C, Ferguson TA. Single-incision anterior approach for total
hip arthroplasty on an orthopaedic table. Clin Orthop Relat Res 2005;441:115.
9. Mayr E, Nogler M, Benedetti MG, et al. A prospective randomized assessment of
earlier functional recovery in THA patients treated by minimally invasive direct
anterior approach: a gait analysis study. Clin Biomech (Bristol, Avon)
2009;24(10):812.Please cite this article in press as: N.M. Joseph, et al., Financial impact of tot
approaches, Arthroplasty Today (2016), http://dx.doi.org/10.1016/j.artd.2010. Siguier T, Siguier M, Brumpt B. Mini-incision anterior approach does not in-
crease dislocation rate: a study of 1037 total hip replacements. Clin Orthop
Relat Res 2004;426:164.
11. Barrett WP, Turner SE, Leopold JP. Prospective randomized study of direct
anterior vs postero-lateral approach for total hip arthroplasty. J Arthroplasty
2013;28:1634.
12. Zawadsky MW, Paulus MC, Murray PJ, Johansen MA. Early outcome compari-
son between the direct anterior approach and the mini-incision posterior
approach for primary total hip arthroplasty: 150 consecutive cases.
J Arthroplasty 2014;29(6):1256.
13. Alecci V, Valente M, Crucil M, et al. Comparison of primary total hip re-
placements performed with a direct anterior approach versus the standard
lateral approach: perioperative ﬁndings. J Orthop Trauma 2011;12:123.
14. Martin CT, Pugely AJ, Gao Y, Clark CR. A comparison of hospital length of stay
and short-term morbidity between the anterior and the posterior approaches
to total hip arthroplasty. J Arthroplasty 2013;28(5):849.
15. Restrepo C, Parvizi J, Pour AE, Hozack WJ. Prospective randomized study of
two surgical approaches for total hip arthroplasty. J Arthroplasty 2010;25(5):
671.
16. Bergin PF, Dopplet JD, Kephart CJ, et al. Comparison of minimally invasive
direct anterior versus posterior total hip arthroplasty based on inﬂammation
and muscle damage markers. J Bone Joint Surg Am 2011;93:1392.
17. Meneghini RM, Pagnano MW, Trousdale RT, Hozack WJ. Muscle damage during
MIS total hip arthroplasty: Smith-Petersen versus posterior approach. Clin
Orthop Relat Res 2006;453:293.
18. Bremer AK, Kalberer F, Pﬁrrmann CW, Dora C. Soft-tissue changes in hip
abductor muscles and tendons after total hip replacement: comparison be-
tween the direct anterior and the transgluteal approaches. J Bone Joint Surg Br
2011;93(7):886.
19. Fehring TK, Odum SM, Troyer JL, et al. Joint replacement access in 2016: a
supply side crisis. J Arthroplasty 2010;25(8):1175.
20. Kurtz SM, Ong K, Lau EC, Mowat F, Halpern M. Projections of primary and
revision hip and knee arthroplasty in the United States from 2005 to 2030.
J Bone Joint Surg Am 2007;89(4):780.
21. Berend KR, Lombardi AV, Seng BE, Adams JB. Enhanced early outcomes with
the anterior supine intermuscular approach in primary total hip arthroplasty.
J Bone Joint Surg Am 2009;91:107.
22. Hoppenfeld S, DeBoer P, Buckley R. Surgical exposures in orthopaedics: the
anatomic approach. Philadelphia, PA: Lippincott Williams and Wilkins; 2009.
23. Tippets DM, Zaryanov AV, Burke VW, et al. Incidence of heterotopic ossiﬁcation
in direct anterior total hip arthroplasty: a retrospective radiographic review.
J Arthroplasty 2014;29(9):1835.
24. Smith TO, Blake V, Hing CB. Minimally invasive versus conventional exposure
for total hip arthroplasty: a systematic review and meta-analysis of clinical and
radiological outcomes. Int Orthop 2011;35(2):173.
25. Goytia RN, Jones LC, Hungerford MW. Learning curve for the anterior approach
total hip arthroplasty. J Surg Orthop Adv 2012;21(2):78.
26. Christensen CP, Karthikeyan TK, Jacobs CA. Greater prevalence of wound
complications requiring reoperation with direct anterior approach total hip
arthroplasty. J Arthroplasty 2014;29(9):1839.
27. Lehil MS, Bozic KJ. Trends in total hip arthroplasty implant utilization in the
United States. J Arthroplasty 2014;29(10):1915.
28. Pour AE, Parvizi J, Sharkey PF, Hozack WJ, Rothman RH. Minimally invasive hip
arthroplasty: what role does patient preconditioning play? J Bone Joint Surg
Am 2007;89(9):1920.al hip arthroplasty: a comparison of anterior versus posterior surgical
16.01.002
